Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness). - Taji T; Uemura Y; Kimura Y; Maeda N; Ito A; Seki H; Takabatake D; Harao M; Nakamoto S; Matsunuma R; Koganezawa C; Iwamoto T; et al. (Breast cancer (Tokyo, Japan), 2026)